BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hijioka S, Morizane C, Ikeda M, Ishii H, Okusaka T, Furuse J. Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives. Jpn J Clin Oncol 2021;51:1185-96. [PMID: 34038547 DOI: 10.1093/jjco/hyab076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nanno Y, Toyama H, Matsumoto I, Uemura J, Asari S, Goto T, Lee D, Murakami T, Komatsu S, Yanagimoto H, Kido M, Ajiki T, Okano K, Takeyama Y, Fukumoto T. Reappraisal of Malignant Risk Assessment for Small (≤20 mm) Non-functioning Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2023. [PMID: 36795254 DOI: 10.1245/s10434-023-13193-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 马 明. Advances in Epidemiology, Diagnostics and Drug Treatment of Pancreatic Neuroendocrine Neoplasm. ACM 2023;13:1849-1859. [DOI: 10.12677/acm.2023.132256] [Reference Citation Analysis]
3 Lysanyuk MV, Romashchenko PN, Maistrenko NA. Modern opportunities and problematic aspects of diagnostics and treatment of patients with neuroendocrine tumors. Perm Medical Journal 2022;39:58-68. [DOI: 10.17816/pmj39558-68] [Reference Citation Analysis]
4 Li YL, Cheng ZX, Yu FH, Tian C, Tan HY. Advances in medical treatment for pancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(20): 2163-2175 [DOI: 10.3748/wjg.v28.i20.2163] [Reference Citation Analysis]
5 Takayanagi D, Cho H, Machida E, Kawamura A, Takashima A, Wada S, Tsunoda T, Kohno T, Shiraishi K. Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers (Basel) 2022;14:1119. [PMID: 35267427 DOI: 10.3390/cancers14051119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]